323 studies found for:    Open Studies | "Hepatitis C"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hepatitis C"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults
Conditions: Chronic Hepatitis C;   Hepatitis C (HCV);   Hepatitis C Genotype 1a
Interventions: Drug: ombitasvir/ABT-450/ritonavir;   Drug: dasabuvir;   Drug: ribavirin
2 Recruiting Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults
Conditions: Chronic Hepatitis C;   Hepatitis C (HCV);   Hepatitis C Genotype 1a
Interventions: Drug: ombitasvir/ABT-450/ritonavir;   Drug: dasabuvir;   Drug: ribavirin
3 Recruiting A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection
Conditions: Chronic Hepatitis C;   Hepatitis C Virus
Interventions: Drug: ABT-493;   Drug: ABT-530;   Drug: Ribavirin (RBV);   Drug: ABT-493/ABT-530
4 Recruiting A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection
Conditions: Hepatitis C Viral Infection;   Chronic Hepatitis C;   Hepatitis C (HCV);   Hepatitis C Genotype 4
Interventions: Drug: Faldaprevir;   Drug: TD-6450;   Drug: Ribavirin
5 Recruiting A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Conditions: Hepatitis C Virus Infection;   Chronic Hepatitis C;   Compensated Cirrhosis
Intervention: Drug: ABT-493/ABT-530
6 Recruiting A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults
Conditions: Hepatitis C Infection;   Hepatitis C Virus
Interventions: Drug: Ombitasvir/Paritaprevir/Ritonavir;   Drug: dasabuvir
7 Recruiting A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection
Conditions: Chronic Hepatitis C;   Hepatitis C Virus;   Genotype 3 Hepatitis C Virus
Interventions: Drug: ABT-493/ABT-530;   Drug: sofosbuvir;   Drug: daclatasvir
8 Recruiting The Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4)
Condition: Hepatitis C Virus
Intervention: Drug: ABT-493/ABT-530
9 Recruiting Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection
Condition: Hepatitis C Virus
Interventions: Drug: Simeprevir 150 mg;   Drug: Daclatasvir 60 mg;   Drug: Sofosbuvir 400 mg
10 Unknown  Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
Conditions: HIV Infection;   Hepatitis C
Intervention: Behavioral: Contigent voucher incentive (CVI)
11 Recruiting Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease
Conditions: HCV;   Genotype 1a;   Genotype 4;   Chronic Kidney Disease;   Hepatitis C;   pegIFN;   IFN
Interventions: Drug: Ombitasvir/Paritaprevir/Ritonavir;   Drug: Dasabuvir
12 Unknown  Pioglitazone in Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Pioglitazone
13 Unknown  Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels
Condition: Chronic Hepatitis C
Intervention: Drug: Peg-Interferon alpha2a plus Ribavirin
14 Recruiting A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Condition: Chronic Hepatitis C Infection
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: ribavirin (RBV)
15 Recruiting A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects
Condition: Chronic Hepatitis C Infection
Interventions: Drug: ombitasvir;   Drug: paritaprevir;   Drug: ritonavir;   Drug: dasabuvir;   Drug: ribavirin
16 Unknown  Micro RNA-122 and the Clinical Course of Patients With Chronic Hepatitis C
Condition: Hepatitis C
Intervention:
17 Unknown  Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy
Conditions: Hepatitis C;   Hepatitis B
Intervention: Drug: Pegasys; Copegus.
18 Recruiting A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
Condition: Chronic Hepatitis C Infection
Interventions: Drug: Ombitasvir/ABT-450/r;   Drug: Dasabuvir;   Drug: Sofosbuvir;   Drug: Ribavirin
19 Unknown  Does Vitamin D Improves Sustained Virologic Response (SVR) in Genotype 2,3 Chronic Hepatitis C Patients?
Condition: Hepatitis C
Interventions: Drug: Peg+ Vitamin D+ Ribavirine;   Drug: Peg+ Ribavirine
20 Recruiting Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C
Condition: Hepatitis C
Intervention: Drug: TT-034

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years